Kidder Stephen W Has $4.80 Million Holdings in Danaher Corporation (DHR)

Kidder Stephen W raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 55,921 shares of the conglomerate’s stock after acquiring an additional 2,730 shares during the quarter. Danaher Corporation comprises approximately 1.8% of Kidder Stephen W’s portfolio, making the stock its 24th biggest holding. Kidder Stephen W’s holdings in Danaher Corporation were worth $4,798,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of DHR. Sullivan Bruyette Speros & Blaney LLC raised its holdings in Danaher Corporation by 1.9% during the 1st quarter. Sullivan Bruyette Speros & Blaney LLC now owns 13,565 shares of the conglomerate’s stock valued at $1,160,000 after acquiring an additional 255 shares during the period. Patton Albertson Miller Group LLC raised its holdings in Danaher Corporation by 317.4% during the 1st quarter. Patton Albertson Miller Group LLC now owns 15,023 shares of the conglomerate’s stock valued at $1,249,000 after acquiring an additional 11,424 shares during the period. Venturi Wealth Management LLC bought a new stake in Danaher Corporation during the 1st quarter valued at $267,000. Dynamic Technology Lab Private Ltd bought a new stake in Danaher Corporation during the 1st quarter valued at $618,000. Finally, Alley Co LLC bought a new stake in Danaher Corporation during the 1st quarter valued at $2,173,000. 75.38% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher Corporation (NYSE DHR) opened at $93.19 on Wednesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher Corporation has a 1 year low of $76.27 and a 1 year high of $93.38. The stock has a market cap of $64,920.83, a PE ratio of 23.99, a price-to-earnings-growth ratio of 2.22 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The business had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The company’s revenue was up 9.6% on a year-over-year basis. equities research analysts anticipate that Danaher Corporation will post 3.99 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s payout ratio is 16.52%.

In other Danaher Corporation news, CAO Robert S. Lutz sold 11,189 shares of the company’s stock in a transaction dated Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the sale, the chief accounting officer now directly owns 18,314 shares in the company, valued at $1,678,661.24. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider William King sold 43,688 shares of the company’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the sale, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 279,628 shares of company stock valued at $25,304,394. Company insiders own 12.20% of the company’s stock.

DHR has been the subject of a number of recent analyst reports. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research report on Thursday, October 5th. Cowen and Company restated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 4th. Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Danaher Corporation has a consensus rating of “Buy” and an average price target of $93.31.

ILLEGAL ACTIVITY WARNING: “Kidder Stephen W Has $4.80 Million Holdings in Danaher Corporation (DHR)” was reported by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://www.themarketsdaily.com/2017/11/15/kidder-stephen-w-has-4-80-million-holdings-in-danaher-corporation-dhr.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply